ALK (anaplastic lymphoma kinase) inhibitor
antineoplastisch middel
Lactam
|
|
|
Lorlatinib (substance)
Lorlatinib
Id
782976007
Status
Primitive
Has disposition
Anaplastic lymphoma kinase inhibitor
